This company has no dividend history.
Based on TTM and annual data · Not a buy/sell signal
This company does not pay dividends
No dividend history found in SEC filings.
Does Soleno Therapeutics (SLNO) pay a dividend?
Soleno Therapeutics (SLNO) has never paid a dividend. The business does generate free cash flow of $105 million, so the absence of a dividend is a capital-allocation choice rather than an inability to pay. All figures are computed from company filings; this is analysis, not investment advice.
Frequently asked
Does Soleno Therapeutics (SLNO) pay a dividend?+
No. Soleno Therapeutics (SLNO) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.
How does Soleno Therapeutics return cash to shareholders?+
It largely does not. Soleno Therapeutics pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.
Could Soleno Therapeutics afford to pay a dividend?+
On the numbers, yes. Soleno Therapeutics generated $105 million of free cash flow, which is about $1.99 per share. If it paid out half of that, the dividend would be roughly $0.99 per share. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Soleno Therapeutics.
SourceDividend analysis computed from the 10-Q filed 30 Apr 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 3 Sept 2026. How this is calculated.
Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.
Peers
Pharmaceutical Preparations · Pick stocks to compare with SLNO
Spot a number that looks wrong? Check it in SLNO's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing SLNO
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.